Sukhani told CNBC-TV18, "Ranbaxy Laboratories has been in a roll after that big decline. It has rallied significantly from more than Rs 250. Yesterday it built on some gains even though the markets are flat; I think that should continue today. The stock has broken out decisively over Rs 400 range. So Ranbaxy is a buying opportunity."
He further added, "One should keep a stoploss at Rs 410 but for a positional short-term swing trader, you can look at Rs 460. For somebody who is trading for a day take whatever gains come but one can actually hold the stock."
